Market Tracker

02/27 6:02pm ET

Brainstorm Cell Therapuetics Inc (NASDAQ:BCLI)

4.25
Delayed Data
As of Feb 27
 +0.31 / +7.87%
Today’s Change
2.81
Today|||52-Week Range
8.47
-10.71%
Year-to-Date
No recent news for Brainstorm Cell Therapuetics Inc.

Today’s Trading

Previous close3.94
Today’s open3.90
Day’s range3.90 - 4.47
Volume1,312,122
Average volume (3 months)910,861
Market cap$76.5M
Dividend yield--
Data as of 3:59pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book18.23

Competitors

 Today’s
change
Today’s
% change
CASICASI Pharmaceuticals...+0.06+3.85%
IMUCImmunoCellular Thera...-0.02-3.13%
ABACAoxin Tianli Group I...-0.14-8.34%
--Protea Biosciences G...-0.08-12.14%
Data as of 4:03pm ET, 02/27/2015

Financials

Next reporting dateMarch 2, 2015
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$0.00
Annual profit (last year)-$4.9M
Net profit margin--

Profile

Sector
Electronic Technology
Industry
Computer Peripherals
Chief Executive Officer
Anthony S. Fiorino
President
Chaim Lebovits
Corporate headquarters
New York, New York

Forecasts